Sign in
R

Reena

Research Analyst at Citigroup Inc.

Kuala Lumpur, Kuala Lumpur, Malaysia

No comprehensive LinkedIn or publicly available data could be identified tying a Citigroup Inc. analyst named Reena to a specific analyst role, coverage list, or credential set. Without a valid LinkedIn profile and with no results listing specific job title, sector focus, company coverage, performance metrics, or licensure, a professional summary cannot be provided at this time.

Reena's questions to Travere Therapeutics (TVTX) leadership

Question · Q3 2024

Reena, on for Yigal Nochomovitz at Citigroup Inc., asked for commentary on FILSPARI's compliance and adherence metrics under the monthly REMS monitoring and how these might change with a reduction in monitoring frequency.

Answer

Chief Commercial Officer Peter Heerma stated that compliance and persistency rates are 'really high,' which he attributed to patients experiencing positive results and reaching treatment targets. President and CEO Dr. Eric Dube added that if monitoring frequency is reduced, the company would ensure patients continue to receive the right level of support and engagement.

Ask follow-up questions

Fintool

Fintool can predict Travere Therapeutics logo TVTX's earnings beat/miss a week before the call

Let Fintool AI Agent track Reena for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free